10X Genomics

Forecast & Rating16 analysts currently cover 10X Genomics, with about 37.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $41.54, about 13.6% downside from the current price of $48.06. Price targets range from $25.00 to $50.00 — a wide spread, showing clear disagreement over just how much 10X Genomics can rise. Historically, about 47.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on 10X Genomics's outlook. Data as of Jul 22, 2026; for reference only and not investment advice.